Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Contrast-enhanced ultrasound for evaluating the pathologic response of breast cancer to neoadjuvant chemotherapy: A meta-analysis.

Jia K, Li L, Wu XJ, Hao MJ, Xue HY.

Medicine (Baltimore). 2019 Jan;98(4):e14258. doi: 10.1097/MD.0000000000014258.

2.
3.

MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway.

Wang N, Hou MS, Zhan Y, Shen XB, Xue HY.

Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):7653-7659. doi: 10.26355/eurrev_201811_16382.

4.

Optimization of the ultrafiltration-assisted extraction of Chinese yam polysaccharide using response surface methodology and its biological activity.

Xue HY, Li JR, Liu YG, Gao Q, Wang XW, Zhang JW, Tanokura M, Xue YL.

Int J Biol Macromol. 2019 Jan;121:1186-1193. doi: 10.1016/j.ijbiomac.2018.10.126. Epub 2018 Oct 17.

PMID:
30342144
5.

Guidelines and recommendations on the clinical use of shear wave elastography for evaluating thyroid nodule1.

Xu HX, Yan K, Liu BJ, Liu WY, Tang LN, Zhou Q, Wu JY, Xue ES, Shen B, Tang Q, Chen Q, Xue HY, Li YJ, Guo J, Wang B, Li F, Yan CY, Li QS, Wang YQ, Zhang W, Wu CJ, Yu WH, Zhou SJ.

Clin Hemorheol Microcirc. 2018 Oct 10. doi: 10.3233/CH-180452. [Epub ahead of print]

PMID:
30320562
6.

Adjustable V-Flap Epicanthoplasty Based on Desired Eyelid Morphology.

Zhang S, Xue HY.

Aesthetic Plast Surg. 2018 Dec;42(6):1571-1575. doi: 10.1007/s00266-018-1193-z. Epub 2018 Sep 14.

PMID:
30218152
7.

Therapeutic Nanotechnology for Bone Infection Treatment - State of the Art.

Guo P, Xue HY, Wong HL.

Curr Drug Deliv. 2018;15(7):941-952. doi: 10.2174/1567201815666180228162949. Review.

PMID:
29493453
8.

In vitro Flow Perfusion Maintaining Long-term Viability of the Rat Groin Fat Flap: A Novel Model for Research on Large-scale Engineered Tissues.

An Y, Nie FF, Qin ZL, Xue HY, Chen LJ, Li B, Li D.

Chin Med J (Engl). 2018 Jan 20;131(2):213-217. doi: 10.4103/0366-6999.222334.

9.

Nanomedicine applications in the treatment of breast cancer: current state of the art.

Wu D, Si M, Xue HY, Wong HL.

Int J Nanomedicine. 2017 Aug 16;12:5879-5892. doi: 10.2147/IJN.S123437. eCollection 2017. Review.

10.

Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome: A Randomized Clinical Trial.

Wu XK, Stener-Victorin E, Kuang HY, Ma HL, Gao JS, Xie LZ, Hou LH, Hu ZX, Shao XG, Ge J, Zhang JF, Xue HY, Xu XF, Liang RN, Ma HX, Yang HW, Li WL, Huang DM, Sun Y, Hao CF, Du SM, Yang ZW, Wang X, Yan Y, Chen XH, Fu P, Ding CF, Gao YQ, Zhou ZM, Wang CC, Wu TX, Liu JP, Ng EHY, Legro RS, Zhang H; PCOSAct Study Group.

JAMA. 2017 Jun 27;317(24):2502-2514. doi: 10.1001/jama.2017.7217.

11.

A new wortmannine derivative from a Tripterygium wilfordii endophytic fungus Talaromyces wortmannii LGT-4.

Sun JY, Yang ZD, Fu GC, Wang YG, Xue HY, Shu ZM.

Nat Prod Res. 2017 Nov;31(21):2527-2530. doi: 10.1080/14786419.2017.1317773. Epub 2017 Apr 20.

PMID:
28423923
12.

Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma.

Xue HY, Liu Y, Liao JZ, Lin JS, Li B, Yuan WG, Lee RJ, Li L, Xu CR, He XX.

Oncotarget. 2016 Dec 27;7(52):86675-86686. doi: 10.18632/oncotarget.13431.

13.

Identification of potential peripheral blood diagnostic biomarkers for patients with juvenile idiopathic arthritis by bioinformatics analysis.

Tu ZQ, Xue HY, Chen W, Cao LF, Zhang WQ.

Rheumatol Int. 2017 Mar;37(3):423-434. doi: 10.1007/s00296-016-3607-z. Epub 2016 Nov 19.

PMID:
27866247
14.

A biodistribution study of solid lipid-polyethyleneimine hybrid nanocarrier for cancer RNAi therapy.

Xue HY, Tran N, Wong HL.

Eur J Pharm Biopharm. 2016 Nov;108:68-75. doi: 10.1016/j.ejpb.2016.08.014. Epub 2016 Aug 26.

15.

Colletotrilactam A-D, novel lactams from Colletotrichum gloeosporioides GT-7, a fungal endophyte of Uncaria rhynchophylla.

Wei B, Yang ZD, Chen XW, Zhou SY, Yu HT, Sun JY, Yao XJ, Wang YG, Xue HY.

Fitoterapia. 2016 Sep;113:158-63. doi: 10.1016/j.fitote.2016.08.005. Epub 2016 Aug 9.

PMID:
27520493
16.

Development and evaluation of viscosity-enhanced nanocarrier (VEN) for oral insulin delivery.

Boushra M, Tous S, Fetih G, Korzekwa K, Lebo DB, Xue HY, Wong HL.

Int J Pharm. 2016 Sep 10;511(1):462-472. doi: 10.1016/j.ijpharm.2016.07.016. Epub 2016 Jul 11.

PMID:
27418563
17.

Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome.

Wu XK, Wang YY, Liu JP, Liang RN, Xue HY, Ma HX, Shao XG, Ng EH; Reproductive and Developmental Network in Chinese Medicine.

Fertil Steril. 2016 Sep 1;106(3):757-765.e1. doi: 10.1016/j.fertnstert.2016.05.022. Epub 2016 Jun 20.

PMID:
27336209
18.

Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives.

Zhang RX, Wong HL, Xue HY, Eoh JY, Wu XY.

J Control Release. 2016 Oct 28;240:489-503. doi: 10.1016/j.jconrel.2016.06.012. Epub 2016 Jun 8. Review.

19.

Resveratrol ameliorates renal injury in spontaneously hypertensive rats by inhibiting renal micro-inflammation.

Xue HY, Yuan L, Cao YJ, Fan YP, Chen XL, Huang XZ.

Biosci Rep. 2016 Jun 3;36(3). pii: e00339. doi: 10.1042/BSR20160035. Print 2016 Jul.

20.

In vivo gene therapy potentials of CRISPR-Cas9.

Xue HY, Zhang X, Wang Y, Xiaojie L, Dai WJ, Xu Y.

Gene Ther. 2016 Jul;23(7):557-9. doi: 10.1038/gt.2016.25. Epub 2016 Mar 31. No abstract available.

PMID:
27029608
21.

Methocel-Lipid Hybrid Nanocarrier for Efficient Oral Insulin Delivery.

Boushra M, Tous S, Fetih G, Xue HY, Tran NT, Wong HL.

J Pharm Sci. 2016 May;105(5):1733-1740. doi: 10.1016/j.xphs.2016.02.018. Epub 2016 Mar 22.

PMID:
27012226
22.

CRISPR-Cas9 for medical genetic screens: applications and future perspectives.

Xue HY, Ji LJ, Gao AM, Liu P, He JD, Lu XJ.

J Med Genet. 2016 Feb;53(2):91-7. doi: 10.1136/jmedgenet-2015-103409. Epub 2015 Dec 16. Review.

PMID:
26673779
23.

Lipid-Based Nanocarriers for RNA Delivery.

Xue HY, Guo P, Wen WC, Wong HL.

Curr Pharm Des. 2015;21(22):3140-7. Review.

24.

[Tissue cultivation of Lonicera macranthoides 'Yuleil'].

Li Q, Jiang FQ, Tan YY, Xue HY.

Zhong Yao Cai. 2014 Jul;37(7):1121-5. Chinese.

PMID:
25566642
25.

Measuring the content of 17 elements in the flesh of Prunus cerasifera and its cultivars by ICP-MS.

Shen J, Xue HY, Li GR, Lu Y, Yao J.

Guang Pu Xue Yu Guang Pu Fen Xi. 2014 Sep;34(9):2557-60.

PMID:
25532363
26.

[Application of asthma predictive index-based group therapy in wheezing children under 5 years of age].

Li YQ, Xue HY, Chen W, Cao LF.

Zhongguo Dang Dai Er Ke Za Zhi. 2014 Aug;16(8):795-9. Chinese.

27.

A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer.

Narvekar M, Xue HY, Tran NT, Mikhael M, Wong HL.

Eur J Pharm Biopharm. 2014 Sep;88(1):226-37. doi: 10.1016/j.ejpb.2014.04.014. Epub 2014 May 9.

PMID:
24816129
28.

Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.

Narvekar M, Xue HY, Eoh JY, Wong HL.

AAPS PharmSciTech. 2014 Aug;15(4):822-33. doi: 10.1208/s12249-014-0107-x. Epub 2014 Apr 2. Review.

29.

Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Xue HY, Liu S, Wong HL.

Nanomedicine (Lond). 2014 Feb;9(2):295-312. doi: 10.2217/nnm.13.204. Review.

30.

[Characteristics of soil nematode community in Abies georgei var. smithii forest gaps in south-east Tibet, China].

Xue HY, Luo DQ.

Ying Yong Sheng Tai Xue Bao. 2013 Sep;24(9):2494-502. Chinese.

PMID:
24417106
31.

[Determination of elements in branches and leaves and the fruits of Sorbus tianschanica Ruper. from different habitats in Xinjiang by microwave digestion-ICP-AES].

He JW, Chang JM, Yao J, Zhang Q, Xue HY, Liu YH.

Guang Pu Xue Yu Guang Pu Fen Xi. 2013 Feb;33(2):544-7. Chinese.

PMID:
23697151
32.

[Community characteristics of soil nematode in Abies georgei var. smithii forest in Sejila Mountain of Tibet, Southwest China].

Xue HY, Luo DQ, Yu BZ.

Ying Yong Sheng Tai Xue Bao. 2012 Dec;23(12):3402-8. Chinese.

PMID:
23479883
33.

Lipid encapsulation of cationic polymers in hybrid nanocarriers reduces their non-specific toxicity to breast epithelial cells.

Xue HY, Narvikar M, Zhao JB, Wong HL.

Pharm Res. 2013 Feb;30(2):572-83. doi: 10.1007/s11095-012-0902-6. Epub 2012 Nov 8.

PMID:
23135818
34.

A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA).

Narvekar M, Xue HY, Wong HL.

Int J Pharm. 2012 Oct 15;436(1-2):721-31. doi: 10.1016/j.ijpharm.2012.07.042. Epub 2012 Jul 28.

PMID:
22850294
35.

Neuroprotective properties of aucubin in diabetic rats and diabetic encephalopathy rats.

Xue HY, Lu YN, Fang XM, Xu YP, Gao GZ, Jin LJ.

Mol Biol Rep. 2012 Oct;39(10):9311-8. doi: 10.1007/s11033-012-1730-9. Epub 2012 Jul 19.

PMID:
22810648
36.

4-[(2'-Cyano-biphenyl-4-yl)meth-yl]morpholin-4-ium hexa-fluoridophosphate.

Xue HY, Wang SJ.

Acta Crystallogr Sect E Struct Rep Online. 2012 May 1;68(Pt 5):o1382. doi: 10.1107/S160053681201358X. Epub 2012 Apr 13.

37.

Targeting megalin to enhance delivery of anti-clusterin small-interfering RNA nanomedicine to chemo-treated breast cancer.

Xue HY, Wong HL.

Eur J Pharm Biopharm. 2012 May;81(1):24-32. doi: 10.1016/j.ejpb.2012.02.005. Epub 2012 Feb 18.

PMID:
22369881
38.
39.

Protective effects of aucubin on H₂O₂-induced apoptosis in PC12 cells.

Xue HY, Gao GZ, Lin QY, Jin LJ, Xu YP.

Phytother Res. 2012 Mar;26(3):369-74. doi: 10.1002/ptr.3562. Epub 2011 Jul 5.

PMID:
21728203
40.

Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitization.

Xue HY, Wong HL.

Biomaterials. 2011 Apr;32(10):2662-72. doi: 10.1016/j.biomaterials.2010.12.029. Epub 2011 Jan 14.

PMID:
21236485
41.

Aucubin modulates Bcl-2 family proteins expression and inhibits caspases cascade in H₂O₂-induced PC12 cells.

Xue HY, Niu DY, Gao GZ, Lin QY, Jin LJ, Xu YP.

Mol Biol Rep. 2011 Jun;38(5):3561-7. doi: 10.1007/s11033-010-0466-7. Epub 2010 Dec 1.

PMID:
21120620
42.

Oral supplementation of catalpol ameliorates diabetic encephalopathy in rats.

Wang CF, Li DQ, Xue HY, Hu B.

Brain Res. 2010 Jan 11;1307:158-65. doi: 10.1016/j.brainres.2009.10.034. Epub 2009 Oct 21.

PMID:
19852947
43.

Aucubin prevents loss of hippocampal neurons and regulates antioxidative activity in diabetic encephalopathy rats.

Xue HY, Jin L, Jin LJ, Li XY, Zhang P, Ma YS, Lu YN, Xia YQ, Xu YP.

Phytother Res. 2009 Jul;23(7):980-6. doi: 10.1002/ptr.2734.

PMID:
19140154
44.

Acanthopanax senticosus suppresses reactive oxygen species production by mouse peritoneal macrophages in vitro and in vivo.

Lin QY, Jin LJ, Cao ZH, Lu YN, Xue HY, Xu YP.

Phytother Res. 2008 Jun;22(6):740-5. doi: 10.1002/ptr.2341.

PMID:
18446849
45.

Antioxidant and pancreas-protective effect of aucubin on rats with streptozotocin-induced diabetes.

Jin L, Xue HY, Jin LJ, Li SY, Xu YP.

Eur J Pharmacol. 2008 Mar 17;582(1-3):162-7. doi: 10.1016/j.ejphar.2007.12.011. Epub 2007 Dec 23.

PMID:
18230397
46.

[In-operation adjusting in inferior pedicle technique reduction mammaplasty].

Chen YZ, Xue HY, Zhu L, You WT, Ma YG, Wang X.

Zhonghua Zheng Xing Wai Ke Za Zhi. 2006 Nov;22(6):422-4. Chinese.

PMID:
17285997
47.

A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.

Wong HL, Bendayan R, Rauth AM, Xue HY, Babakhanian K, Wu XY.

J Pharmacol Exp Ther. 2006 Jun;317(3):1372-81. Epub 2006 Mar 17.

PMID:
16547167
48.

[Levels of serum interleukin-15 and the expression of T-helper lymphocyte subsets in peripheral blood of children with juvenile rheumatoid arthritis].

Cao LF, Lu YM, Ma M, Xue HY, Zhao Y, Yu HQ, Mao HY, Gu YY.

Zhongguo Dang Dai Er Ke Za Zhi. 2006 Feb;8(1):9-12. Chinese.

PMID:
16522230
49.
50.

Engineering lipobeads: properties of the hydrogel core and the lipid bilayer shell.

Buck S, Pennefather PS, Xue HY, Grant J, Cheng YL, Allen CJ.

Biomacromolecules. 2004 Nov-Dec;5(6):2230-7.

PMID:
15530037

Supplemental Content

Support Center